<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(2)</volume><submitter>Yang Q</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Although surgical treatment of residual obstruction after alcohol septal ablation (ASA) is often challenging in patients with obstructive hypertrophic cardiomyopathy (OHCM) there are very few relevant clinical reports. Thus, outcomes of surgical septal myectomy (SSM) in this subgroup of patients remain to be determined. Therefore, this study aimed to determine the surgical and follow-up outcomes in patients with OHCM exhibiting residual obstruction after ASA.&lt;h4>Methods&lt;/h4>We collected case data for 62 patients with OHCM and residual obstruction after ASA who underwent SSM at Fuwai Hospital between January 2002 and June 2019. Propensity score matching with patients having had a myectomy as the only invasive procedure-was conducted in a 1:2 ratio. Echocardiography parame</pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>1055-1065</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7947546</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation.</pubmed_title><pmcid>PMC7947546</pmcid><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Yu Q</pubmed_authors><pubmed_authors>Cui H</pubmed_authors><pubmed_authors>Tang B</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation.</name><description>&lt;h4>Background&lt;/h4>Although surgical treatment of residual obstruction after alcohol septal ablation (ASA) is often challenging in patients with obstructive hypertrophic cardiomyopathy (OHCM) there are very few relevant clinical reports. Thus, outcomes of surgical septal myectomy (SSM) in this subgroup of patients remain to be determined. Therefore, this study aimed to determine the surgical and follow-up outcomes in patients with OHCM exhibiting residual obstruction after ASA.&lt;h4>Methods&lt;/h4>We collected case data for 62 patients with OHCM and residual obstruction after ASA who underwent SSM at Fuwai Hospital between January 2002 and June 2019. Propensity score matching with patients having had a myectomy as the only invasive procedure-was conducted in a 1:2 ratio. Echocardiography parame</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-04T19:54:16.131Z</modification><creation>2025-04-04T19:54:16.131Z</creation></dates><accession>S-EPMC7947546</accession><cross_references><pubmed>33717578</pubmed><doi>10.21037/jtd-20-2779</doi></cross_references></HashMap>